Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Feb;17(2):247-50.
doi: 10.1128/AAC.17.2.247.

Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae

Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae

M F Rein et al. Antimicrob Agents Chemother. 1980 Feb.

Abstract

Sulfamethoxazole and trimethoprim are synergistic against many bacteria in sulfamethoxazole/trimethoprim concentrations of 20:1, but single-dose therapy of gonorrhea with the combination is disappointing. We used agar dilution techniques to determine minimal inhibitory concentrations of sulfamethoxazole and trimethoprim for 168 gonococci isolated from men with acute urethritis in Atlanta, Ga. The geometric mean minimal inhibitory concentrations were 5.6 microgram of sulfamethoxazole per ml and 24.3 microgram of trimethoprim per ml, a ratio of 1:4. The concentration of sulfamethoxazole inhibiting 50% of gonococcal strains dropped only from 4.7 microgram/ml to 2.9 microgram/ml with the addition of a 1/20 dilution of trimethoprim. We studied synergism with various ratios of sulfamethoxazole to trimethoprim against 20 random strains. A ratio of 1:1 was always synergistic and was the most synergistic ratio for 15 strains, whereas the 19:1 ratio was never the most syngergistic. The 19:1 ratio failed to show synergism against seven strains, but showed antagonism at this ratio with five of these seven. The sulfamethoxazole/trimethoprim ratio of 19:1 usually achieved in serum after oral administration is minimally syngergistic and is sometimes antagonistic for gonococci.

PubMed Disclaimer

References

    1. Lancet. 1970 Feb 7;1(7641):263-5 - PubMed
    1. J Clin Pharmacol. 1974 Feb-Mar;14(2):112-7 - PubMed
    1. Antimicrob Agents Chemother. 1972 Apr;1(4):283-8 - PubMed
    1. Br J Vener Dis. 1974 Dec;50(6):447-9 - PubMed
    1. Br J Vener Dis. 1975 Jun;51(3):179-82 - PubMed

MeSH terms

LinkOut - more resources